Screener
Citius Oncology, Inc. CTOR Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$8.92M-66.2% | -$26.61M-244% | -$5.53M+16.9% | -$5M+26.7% | -$5.37M-12.5% | ||
| $3.56M+67.5% | $3.53M+68.9% | $3.96M+119% | $2.3M+37.8% | $2.13M+8.6% | ||
| -$2.71M-97.4% | -$3.83M-179% | -$7.35M-436% | -$1.37M-301% | -$1.37M-4,447% | ||
| -$2M-39.1% | -$600K+58.3% | -$4.4M-206% | -$1.44M+95.2% | -$1.44M-15.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $20M-60.0% | —— | ||
| $18.64M+392% | —— | $15.13M+299% | $3.79M-87.0% | $3.79M+211% | ||
| $13.93M+1,320% | -$4.66M-575% | $3.37M+244% | $981.2K+538% | $981.2K— |
FAQ
- How much cash does Citius Oncology, Inc. generate?
- Citius Oncology, Inc. (CTOR) generated -$15.3M in operating cash flow over the trailing twelve months.
- Where does Citius Oncology, Inc.'s cash flow data come from?
- Every line is extracted from Citius Oncology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.